Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Jaguar Health (JAGX) Accumulated Depreciation & Amortization (2016 - 2025)

Historic Accumulated Depreciation & Amortization for Jaguar Health (JAGX) over the last 11 years, with Q3 2025 value amounting to $550000.0.

  • Jaguar Health's Accumulated Depreciation & Amortization rose 978.04% to $550000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $550000.0, marking a year-over-year increase of 978.04%. This contributed to the annual value of $513000.0 for FY2024, which is 1032.26% up from last year.
  • Jaguar Health's Accumulated Depreciation & Amortization amounted to $550000.0 in Q3 2025, which was up 978.04% from $536000.0 recorded in Q2 2025.
  • Over the past 5 years, Jaguar Health's Accumulated Depreciation & Amortization peaked at $550000.0 during Q3 2025, and registered a low of $274000.0 during Q1 2021.
  • Its 5-year average for Accumulated Depreciation & Amortization is $432894.7, with a median of $450000.0 in 2023.
  • In the last 5 years, Jaguar Health's Accumulated Depreciation & Amortization surged by 5655.17% in 2022 and then plummeted by 91.12% in 2023.
  • Over the past 5 years, Jaguar Health's Accumulated Depreciation & Amortization (Quarter) stood at $298000.0 in 2021, then skyrocketed by 35.57% to $404000.0 in 2022, then increased by 15.1% to $465000.0 in 2023, then grew by 10.32% to $513000.0 in 2024, then grew by 7.21% to $550000.0 in 2025.
  • Its last three reported values are $550000.0 in Q3 2025, $536000.0 for Q2 2025, and $525000.0 during Q1 2025.